Biomed. Papers 146(2), 59-61 (2002) | DOI: 10.5507/bp.2002.012

Monitoring of bone resorption and bone formation in multiple myeloma.

Jaroslav Bačovský, Vlastimil ©čudla, Markéta Vytřasová, Marie Budíková, Miroslav Mysliveček
III. Department of Internal Medicine of Palacký University, Olomouc, Czech Republic
Department of Nuclear Medicine of Palacký University, Olomouc, Czech Republic

The article deals with the clinical value of monitoring of serum markers of osteoresorption (ICTP) and bone formation (PICP) in multiple myeloma. In a group of patients treated by conventional chemotherapy and group of patients treated by high dose chemotherapy with autologous peripheral blood stemm cell transplantation (APBSTC).

Keywords: Multiple myeloma, Osteoresorption

Received: September 20, 2002; Published: December 1, 2002  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bačovský, J., ©čudla, V., Vytřasová, M., Budíková, M., & Mysliveček, M. (2002). Monitoring of bone resorption and bone formation in multiple myeloma. Biomedical papers, 146(2), 59-61. doi: 10.5507/bp.2002.012
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Abildgaard N, Nielsen JL, Heickendorf L (1994) Connective tissue components in serum in multiple myeloma: analyses of propeptides of type I and type III procollagens, type I collagen telopeptide and hyaluronan. American Journal of Hematology 46, 173-178. DOI: 10.1002/ajh.2830460303 Go to original source... Go to PubMed...
    2. Abildgaaard N, Bentzen SM, Nielsen JL, Heickendorff L (1997) Serum markers of bone metabolism in multiple myeloma: prognostic value of the carboxy-terminal telopeptide of type I collagen. Br J Haematol 96 (1), 103-10. DOI: 10.1046/j.1365-2141.1997.8672495.x Go to original source... Go to PubMed...
    3. Blomquist C, Risteli L, Risteli J. (1999) Markers of type I collagen degradation and synthesis in monitoring of treatment response in bone metastases from breast carcinoma. Br J Cancer, 73 (9), 1074-9. Go to original source... Go to PubMed...
    4. Carlson K, Larsson A, Simonson B, et al. (1999) Evaluation of bone disease in multiple myeloma a comparison between the resorption markers urinary deoxypyridinoline / creatinine (DPD) and serum ICTP, and an evaluation of DPD / osteocalcin and ICTP /osteocalcin ratios. Eur J Haematol, 62 (5), 300-6. Go to original source... Go to PubMed...
    5. Fonseca R, Trendle MC, Leong T, Kyle RA, et al. (2000) Prognostic value of serum markers of bone metabolism in untreated multiple myeloma patients. Br J Haematol, 109 (1), 249. Go to original source... Go to PubMed...
    6. Risteli J, Elomaa I, Niemi S, et al. (1993) Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: new serum marker of bone collagen degradation. Clin Chem 39 (4), 635-40. Go to original source...
    7. Tanaka K, Shiraishi K, et al. (1998) Serum levels of carboxyterminal propeptide of type I procollagen (PICP), cross-linked carboxyterminal telopeptide region of type I collagen (ICTP) carboxyterminal parathyroid hormone-related protein (C-PTHrP) in hematological malignancies with bone lesions and hypercalcemia. Rinsho Ketsueki, 39 (4), 273-80. Go to PubMed...

    Return to the content